Full Name
Christopher Missling
Job Title
CEO
Company
Anavex Life Sciences Corp
Speaker Bio
Christopher U. Missling, PhD is President and CEO of Anavex Life Sciences Corp, has over 20 years of healthcare industry experience within large pharmaceutical companies and the biotech industry. Prior to joining Anavex, he served as the Chief Financial Officer of Curis and ImmunoGen. In addition, at Aventis (now Sanofi), Christopher’s work is dedicated to finding potential cures for neurodegenerative and neurodevelopmental diseases, like Alzheimer’s disease, and Parkinson’s disease, as well as, Rett syndrome, Fragile X, Angelman’s syndrome, infantile spasms. Dr. Missling is working with his team to advance new potential treatments through clinical trials by involving the respective advocacy groups early on. Dr. Missling has an MS and PhD from the University of Munich in Chemistry and an MBA from Northwestern University Kellogg School of Management and WHU Otto Beisheim School of Management.
Christopher Missling